Company Filing History:
Years Active: 2016
Title: Kawasaki Masanori: Innovator in Pharmaceutical Research
Introduction
Kawasaki Masanori is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific health conditions. His work is characterized by a focus on innovative solutions for complex medical issues.
Latest Patents
Kawasaki holds 1 patent for his invention titled "Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors." This invention provides a compound with selective inhibitory action on PDE2A, which is useful in the prophylaxis or treatment of schizophrenia, Alzheimer's disease, and similar conditions. The compound is represented by a specific formula, with each symbol detailed in the patent specification.
Career Highlights
Kawasaki Masanori is associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His role at Takeda has allowed him to engage in cutting-edge research and development, contributing to the advancement of therapeutic options for patients.
Collaborations
Kawasaki has collaborated with notable colleagues in his field, including Shinji Nakamura and Satoshi Mikami. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic agents.
Conclusion
Kawasaki Masanori's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions, particularly in the area of PDE2A inhibitors, highlight the importance of targeted therapies in treating complex diseases.